Ampcera has an exclusive licensing agreement with PNNL to commercially develop and license a new battery material for applications such as vehicles and personal electronics.
Scientists map how transitions from day to night control gene regulatory networks in cyanobacteria, revealing key orchestrators of metabolic switching.
PNNL's ASSORT model will help airports balance passenger screening and security risks with throughput. It also quantifies risks for different traveler types and optimizes checkpoint operations, improving efficiency while enhancing safety.
At the 2024 Aviation Futures Workshop, researchers from PNNL joined other subject matter experts and representatives from the stakeholder community in reimagining the passenger experience.
Clean hydrogen energy infrastructure is coming to the Pacific Northwest with a newly announced hydrogen hub, and PNNL experts are advising the work to come.
Scientists developed a process (or pipeline) that combined molecular probes—a specific chemical that binds to microbes carrying out a particular function—with a method that isolated these cells from their complex community.
Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.